Exercise Intervention for People With Schizophrenia (CREW)
CREW
Enhancing Functional Capacity and Body Composition of Individuals With Schizophrenia Through a Physical Exercise Intervention
1 other identifier
interventional
100
1 country
1
Brief Summary
The study aims to investigate the feasibility and adherence of long-term, moderate-intensity different types of physical activity programs for individuals with schizophrenia. Secondary outcomes are related to the control of non-communicable disease risk factors and the improvement of exercise capacity, body composition and cognitive function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Dec 2017
Longer than P75 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 5, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 21, 2023
September 1, 2023
8.1 years
September 5, 2023
September 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Peak Oxygen Uptake (VO2peak)
Measurement of cardiorespiratory fitness, reported as ml/kg/min and estimated through a moderate and perceptually regulated 1km treadmill walk test (1k-TWT) or through related short-forms (500m or 200m)
First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)
Body Mass Index (kg/m²)
Derived from the measurement of weight in kilograms and height in meters
First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)
Waist circumference (cm)
Measurement of waist circumference
First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)
Screen for Cognitive Impairment in Psychiatry (SCIP)
Values range from 0 to \>100, higher scores mean a better outcome
First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)
Frontal Assessment Battery (FAB)
Values range from 0 to18, higher scores mean a better outcome
First assessment at the date of enrolment (baseline) and subsequently every six months until the date of the end of follow-up (up to 2 years)
Secondary Outcomes (1)
Adherence
From date of enrollment until the date of the end of follow-up (up to 2 years)
Study Arms (2)
Physical activity group
EXPERIMENTALParticipation in supervised activities such as walking or Nordic walking groups, gentle gymnastics, soccer, swimming, and volleyball. Each activity was scheduled twice a week.
Usual care group
OTHERParticipants in the control group attended weekly 90-minute cognitive rehabilitation sessions according to the usual care procedure in this type of population.
Interventions
Bi-weekly supervised physical activity intervention
weekly 90-minute session consisting of welcoming participants, reviewing tasks conducted in the last meeting, and assignment of new pen-and-pencil cognitive and metacognitive tasks.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with schizophrenia for at least 1 year
- On antipsychotic medications with the same therapeutic regimen for at least 3 months before enrolment
- Free of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions
You may not qualify if:
- Recent modification of the therapeutic regimen
- Presence of symptomatic peripheral arterial occlusive disease and cardiovascular, pulmonary, neurological, metabolic, and orthopaedic disorders that could interfere with physical activity sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Exercise Science and Sport
Ferrara, 44123, Italy
Related Publications (1)
Mandini S, Morelli M, Belvederi Murri M, Grassi L, Masotti S, Simani L, Zerbini V, Raisi A, Piva T, Grazzi G, Mazzoni G. Adherence to a guided walking program with amelioration of cognitive functions in subjects with schizophrenia even during COVID-19 pandemic. BMC Sports Sci Med Rehabil. 2022 Mar 25;14(1):48. doi: 10.1186/s13102-022-00440-2.
PMID: 35337370RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gianni Mazzoni, Professor
Università degli Studi di Ferrara
- PRINCIPAL INVESTIGATOR
Simona Mandini, PhD
Università degli Studi di Ferrara
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 5, 2023
First Posted
September 21, 2023
Study Start
December 1, 2017
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 21, 2023
Record last verified: 2023-09